Quick Links

Contact Us

Assessment of cardiovascular risk in patients with erectile dysfunction: focus on the diabetic patient.

Authors: Robert A Kloner

Journal: Endocrine

Publication Type: Journal Article

Date: 2004

DOI: 10.1385/ENDO:23:2-3:125

ID: 15146090

Affiliations:

Affiliations

    Heart Institute, Good Samaritan Hospital, and Cardiovascular Division, Keck School of Medicine at University of Southern California, Los Angeles, CA 90017, USA. rkloner@goodsam.org

Abstract

Erectile dysfunction (ED) is commonly associated with risk factors for cardiovascular disease, including diabetes. The prevalence of ED in diabetic patients is high--about 75% of diabetic men 60 yr of age or older had ED in one study. Endothelial dysfunction, accelerated atherosclerosis, and diabetic neuropathy likely contribute to ED in diabetics. As silent ischemia is common in the diabetic patient, and diabetes is now often thought of as a coronary heart disease risk equivalent, diabetic men seeking therapy for ED may be considered candidates for exercise stress testing. Phosphodiesterase 5 (PDE5) inhibitors improve erectile function in diabetic men with ED; however, efficacy rates may be somewhat lower than in nondiabetic men. Studies to date have suggested that PDE5 inhibitors per se do not cause an increase in myocardial infarction rates in men being treated for ED.

Chemical List

    Phosphodiesterase Inhibitors|||3',5'-Cyclic-GMP Phosphodiesterases|||Cyclic Nucleotide Phosphodiesterases, Type 5|||PDE5A protein, human

Reference List

    BJU Int. 2001 Jul;88(1):68-71|||Am J Cardiol. 2002 Jun 1;89(11):1331-4|||JAMA. 1996 May 8;275(18):1405-9|||J Am Coll Cardiol. 2000 Sep;36(3):845-51|||Diabetologia. 2001 Oct;44(10):1296-301|||Diabetes Educ. 1999 Jan-Feb;25(1):79-80, 83-4, 87 passim|||N Engl J Med. 2000 Jun 1;342(22):1622-6|||Am J Cardiol. 2000 Jul 15;86(2):175-81|||Int J Impot Res. 2002 Dec;14(6):466-71|||JAMA. 1993 Jul 7;270(1):83-90|||Diabetologia. 2001 Sep;44(9):1155-60|||JAMA. 2001 May 16;285(19):2486-97|||J Urol. 2001 Oct;166(4):1368-71|||JAMA. 2002 Feb 13;287(6):719-25|||Am J Cardiol. 1999 Feb 15;83(4):576-82, A7|||Diabetes Care. 2002 Aug;25(8):1336-9|||Diabetes Care. 2002 Feb;25(2):284-91|||Diabetes Care. 1996 Feb;19(2):135-41|||Urology. 2002 Sep;60(2 Suppl 2):67-90|||Diabetologia. 1980 Apr;18(4):279-83|||Hosp Med. 1999 Sep;60(9):638-44|||J Am Coll Cardiol. 2002 Dec 4;40(11):2006-12|||Singapore Med J. 2002 Aug;43(8):387-90|||Am J Cardiol. 2000 Jul 20;86(2A):51F-56F|||Am J Hypertens. 2001 Jan;14(1):70-3|||J Urol. 1994 Jan;151(1):54-61